EXAS
USDExact Sciences Corporation Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$70.070
Máximo
$72.810
Mínimo
$67.970
Volume
1.54M
Fundamentos da empresa
Capitalização de mercado
13.2B
Setor
Diagnostics & Research
País
United States
Estatísticas de negociação
Volume médio
2.95M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.
Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80
Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.
Exact Sciences to Participate in November Investor Conference
Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.